Brooks Laboratories Limited (NSE:BROOKS)

India · Delayed Price · Currency is INR

60.00

-0.30 (-0.50%)

Aug 21, 2026, 3:28 PM IST

Brooks Laboratories Financials Overview

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Revenue & Profits

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun '26 Jun 30, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Revenue	831.87	857.38	825.57	794.86	632.05	911.85
Revenue Growth	-7.71%	3.85%	3.86%	25.76%	-30.69%	18.04%
Gross Profit	344.7	338.1	279.36	225.13	107.95	272.06
Operating Income	47.39	60.26	36.81	21.32	-334.02	-213.8
Net Income	132.12	245.84	-99.67	-195.92	-208.92	-112.9
Earnings Per Share	4.49	8.35	-3.72	-7.65	-8.46	-4.57
EPS Growth	513.72%	-	-	-	-	-

Revenue by Segment

Fiscal Year	TTM	FY 2026	FY 2025
Period Ending	Jun '26 Jun 30, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025
Trading	26.89	28.66	24.27
Manufacturing	804.98	828.73	801.3
Total	831.87	857.38	825.57

Cash & Debt

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun '26 Jun 30, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Cash & Investments	66.73	66.73	3.08	1.26	0.23	26.05
Total Debt	85.17	85.17	75.83	56.42	65.12	252.59
Net Cash (Debt)	-18.44	-18.44	-72.75	-55.16	-64.89	-226.54
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share	-0.63	-0.63	-2.72	-2.15	-2.63	-9.17

Cash Flow & CapEx

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun '26 Jun 30, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Operating Cash Flow	-	92.93	26.26	-98.01	-144.9	-374.41
Capital Expenditures	-	-35.06	-9.23	-4.39	-4.68	-276.12
Free Cash Flow	-	57.88	17.04	-102.4	-149.58	-650.53
Free Cash Flow Growth	-	239.75%	-	-	-	-

Margins

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun '26 Jun 30, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Gross Margin	41.44%	39.43%	33.84%	28.32%	17.08%	29.84%
Operating Margin	5.70%	7.03%	4.46%	2.68%	-52.85%	-23.45%
Pretax Margin	15.88%	28.67%	-11.86%	-24.62%	-60.71%	-26.21%
Profit Margin	15.88%	28.67%	-12.07%	-24.65%	-33.05%	-12.38%
FCF Margin	-	6.75%	2.06%	-12.88%	-23.67%	-71.34%

Valuation

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Aug '26 Aug 23, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
PE Ratio	13.36	4.45	-	-	-	-
P/FCF Ratio	30.54	18.89	185.94	-	-	-
PS Ratio	2.12	1.27	3.84	3.09	2.44	1.98